DYN
Dyne Therapeutics Inc

2,673
Mkt Cap
$2.72B
Volume
1.86M
52W High
$25.00
52W Low
$6.36
PE Ratio
-4.59
DYN Fundamentals
Price
$16.99
Prev Close
$16.80
Open
$16.64
50D MA
$18.90
Beta
1.85
Avg. Volume
2.22M
EPS (Annual)
-$3.37
P/B
3.46
Rev/Employee
$0.00
Loading...
Loading...
News
all
press releases
Keros Therapeutics vs. Dyne: Which DMD Biotech Has More Upside?
Keros Therapeutics advances KER-065 toward DMD trials, trims costs, and extends its cash runway as investors weigh it against Dyne???s deeper pipeline
Zacks·14d ago
News Placeholder
More News
News Placeholder
FY2025 Earnings Forecast for DYN Issued By Lifesci Capital
Dyne Therapeutics, Inc. (NASDAQ:DYN - Free Report) - Analysts at Lifesci Capital upped their FY2025 earnings per share estimates for Dyne Therapeutics in a report released on Wednesday, January 21st...
MarketBeat·18d ago
News Placeholder
JPMorgan Chase & Co. Lowers Dyne Therapeutics (NASDAQ:DYN) Price Target to $16.00
JPMorgan Chase & Co. cut their price target on shares of Dyne Therapeutics from $17.00 to $16.00 and set a "neutral" rating for the company in a research report on Tuesday...
MarketBeat·21d ago
News Placeholder
Campbell & CO Investment Adviser LLC Purchases Shares of 64,517 Dyne Therapeutics, Inc. $DYN
Campbell & CO Investment Adviser LLC bought a new stake in Dyne Therapeutics, Inc. (NASDAQ:DYN - Free Report) in the 3rd quarter, according to its most recent filing with the Securities and Exchange...
MarketBeat·21d ago
News Placeholder
Dyne Therapeutics (NASDAQ:DYN) Trading Down 4.9% - Here's What Happened
Dyne Therapeutics (NASDAQ:DYN) Trading Down 4.9% - What's Next...
MarketBeat·26d ago
News Placeholder
Dyne Therapeutics (NASDAQ:DYN) Stock Price Down 6% - Here's What Happened
Dyne Therapeutics (NASDAQ:DYN) Trading Down 6% - Here's What Happened...
MarketBeat·1mo ago
News Placeholder
Dyne Therapeutics (NASDAQ:DYN) Shares Down 6.7% - What's Next?
Dyne Therapeutics (NASDAQ:DYN) Stock Price Down 6.7% - Time to Sell...
MarketBeat·1mo ago
News Placeholder
Dyne Therapeutics (NASDAQ:DYN) Stock Rating Lowered by Wall Street Zen
Wall Street Zen downgraded Dyne Therapeutics from a "hold" rating to a "sell" rating in a report on Sunday...
MarketBeat·1mo ago
News Placeholder
Dyne Therapeutics, Inc. $DYN Shares Purchased by Squarepoint Ops LLC
Squarepoint Ops LLC raised its position in Dyne Therapeutics, Inc. (NASDAQ:DYN - Free Report) by 334.3% during the 2nd quarter, according to its most recent disclosure with the SEC. The fund owned...
MarketBeat·2mo ago
News Placeholder
Dyne Therapeutics (NASDAQ:DYN) Upgraded by Wall Street Zen to Hold Rating
Wall Street Zen raised shares of Dyne Therapeutics from a "sell" rating to a "hold" rating in a research report on Saturday...
MarketBeat·2mo ago
<
1
2
...
>

Latest DYN News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.